Jeffrey S. Hackman

Comera Life Sciences Holdings, Inc.Fennec Pharmaceuticals Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 1 buy · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€6,242

▼ Sales (0 ops.)

—

Latest filing published 13 Oct 2026 for Fennec Pharmaceuticals INC., €11k. Read the official filing

Filing timeline

BuySale

Jeffrey S. Hackman

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Fennec Pharmaceuticals INC. 1 purchase · last 19 May 2025
Comera Life Sciences Holdings, Inc. 1 purchase · last 12 Sept 2022

Since each purchase

Fennec Pharmaceuticals Inc.
Filed 19 May 2025 · 517 days ago · €6,242
+19.3%
Entry US$8.17 · Close at T+365 US$9.75

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Jeffrey S. Hackman: trading record in brief

Filings by Jeffrey S. Hackman span 2 companies, the busiest being Fennec Pharmaceuticals Inc. and Comera Life Sciences Holdings, Inc. We count 12 filings; the first trade dates from 9 September 2022 and the latest from 12 October 2026.

The open-market record is one-sided, with 2 purchases worth €6,242 and not one sale. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants and 5 option exercises.

The record was last updated on 13 October 2026 with a share grant (€11k) in Fennec Pharmaceuticals Inc. The clock since the last published purchase (19 May 2025) now reads 517 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.